LONDON, March 18 (Reuters) - Reckitt said on

Monday that many cases had been filed against baby formula

makers in general, but it was unclear how many directly related

to its unit's Enfamil product.

An Illinois jury last week ordered Reckitt unit Mead

Johnson to pay $60 million to the mother of a premature baby who

died of an intestinal disease after being fed the company's

Enfamil baby formula.

The jury in an Illinois state court in St. Clair County last

week found Mead Johnson was negligent and had failed to warn of

the risk of necrotising enterocolitis (NEC). The disease, which

causes the death of bowel tissue, mostly affects premature

newborns and has a fatality rate of about 15% to 40%.

Traders told Reuters on Friday there were concerns in the

market that more cases would be made against Mead Johnson.

Shares of Reckitt, which owns brands such as Lysol, Dettol and

Strepsils, that day suffered their steepest one-day drop since

1999, making it the top loser on London's blue-chip FTSE 100

.

"Case numbers will continue to fluctuate," an executive said

on a call to discuss last week's verdict. "New cases will be

filed and some will be dismissed. And we need to determine

whether we're actually involved in the litigation."